03/15/2024 3:37 PM | Lonial Sagar (Reporting) TG Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:52 PM | Charney Laurence N (Reporting) TG Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:10 PM | Lonial Sagar (Reporting) TG Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 10:24 AM | Charney Laurence N (Reporting) TG Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:23 PM | TG Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/28/2024 6:24 AM | TG Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:53 PM | Power Sean A (Reporting) TG Therapeutics (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
|
02/14/2024 2:30 PM | Darwin Global Management, Ltd. (Filed by) TG Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024 10:29 AM | STATE STREET CORP (Filed by) TG Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024 6:37 AM | TG Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 5:32 PM | TG Therapeutics (Issuer) WEISS MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 5:33 PM | Charney Laurence N (Reporting) TG Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 4:00 PM | Power Sean A (Reporting) TG Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 10:02 AM | Charney Laurence N (Reporting) TG Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023 6:33 AM | TG Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 8:54 AM | TG Therapeutics (Issuer) WEISS MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2023 3:30 PM | TG Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023 6:29 AM | TG Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2023 4:00 PM | Lonial Sagar (Reporting) TG Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:25 PM | Lonial Sagar (Reporting) TG Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023 5:26 PM | Power Sean A (Reporting) TG Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2023 6:59 AM | TG Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/01/2023 3:17 PM | TG Therapeutics (Filer)
| Form DEF 14A | |
05/01/2023 3:19 PM | TG Therapeutics (Filer)
| Form DEFA14A | |
05/01/2023 6:35 AM | TG Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/21/2023 3:30 PM | TG Therapeutics (Filer)
| Form PRE 14A | |
04/03/2023 7:00 AM | Darwin Global Management, Ltd. (Filed by) TG Therapeutics (Subject)
| Form SC 13G | |